Suspension of trading
Axonics, Inc. Share Price
Equities
AXNX
US05465P1012
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70.98 USD | +0.75% |
|
-.--% | - |
| 18/11/24 | Axonics, Inc.(NasdaqGS:AXNX) dropped from S&P Healthcare Equipment Select Industry Index | CI |
| 18/11/24 | Axonics, Inc.(NasdaqGS:AXNX) dropped from S&P Global BMI Index | CI |
| Capitalization | 3.63B 3.07B 2.81B 2.67B 4.95B 329B 5.17B 32.71B 12.95B 158B 13.61B 13.33B 570B | P/E ratio 2022 |
-48.9x | P/E ratio 2023 | -502x |
|---|---|---|---|---|---|
| Enterprise value | 3.31B 2.8B 2.57B 2.43B 4.52B 300B 4.72B 29.85B 11.82B 144B 12.41B 12.16B 520B | EV / Sales 2022 |
10x | EV / Sales 2023 | 7.74x |
| Free-Float |
99.8% | Yield 2022 * |
-
| Yield 2023 | - |
More valuation ratios
* Estimated data
More news
More recommendations
| 18/11/24 | Boston Scientific Closes Acquisition of Axonics, Inc. | AQ |
| 15/11/24 | Boston Scientific Closes Acquisition of Axonics, Inc. | PR |
| 07/11/24 | Axonics : Reports Third Quarter 2024 Financial Results Form 8 K | PU |
| 07/11/24 | Axonics: Q3 Earnings Snapshot | AQ |
| 07/11/24 | Axonics Reports Third Quarter 2024 Financial Results | BU |
More news
| 1 day | +0.75% |
| 3 years | 47.59 | 71.05 | |
| 5 years | 38.41 | 79.92 | |
| 10 years | 11.95 | 79.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | 53 | 30/09/2013 | |
Kari Keese
DFI | Director of Finance/CFO | 41 | 01/10/2023 |
Rinda Sama
COO | Chief Operating Officer | 47 | 31/07/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert McNamara
BRD | Director/Board Member | 69 | 31/01/2018 |
Michael Carrel
CHM | Chairman | 55 | 28/04/2020 |
Nancy Snyderman
BRD | Director/Board Member | 74 | 07/04/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.75% | -.--% | -.--% | +20.65% | 3.63B | ||
| -1.14% | -3.05% | -8.46% | +31.51% | 137B | ||
| -2.05% | +2.01% | +26.51% | +7.97% | 14.65B | ||
| -2.30% | +7.65% | -14.66% | -63.78% | 6.53B | ||
| -0.88% | -5.75% | -26.50% | +127.22% | 6.46B | ||
| -1.06% | -2.97% | +40.86% | +33.36% | 2.91B | ||
| -1.18% | -1.64% | -1.65% | -18.99% | 2.09B | ||
| +0.15% | -13.30% | -63.93% | -73.68% | 1.91B | ||
| Average | -0.96% | -1.62% | -5.98% | +8.03% | 21.9B | |
| Weighted average by Cap. | -1.20% | -2.32% | -5.96% | +27.57% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 274M 232M 212M 201M 373M 24.8B 390M 2.47B 977M 11.94B 1.03B 1.01B 42.97B | 366M 310M 284M 269M 500M 33.19B 523M 3.3B 1.31B 15.98B 1.37B 1.35B 57.52B |
| Net income | -59.7M -50.53M -46.32M -43.87M -81.45M -5.41B -85.16M -538M -213M -2.6B -224M -219M -9.37B | -6.09M -5.15M -4.72M -4.47M -8.31M -552M -8.68M -54.89M -21.73M -266M -22.83M -22.36M -956M |
| Net Debt | -348M -295M -270M -256M -475M -31.54B -497M -3.14B -1.24B -15.18B -1.31B -1.28B -54.65B | -317M -269M -246M -233M -433M -28.75B -453M -2.86B -1.13B -13.84B -1.19B -1.17B -49.82B |
More financial data
* Estimated data
Employees
797
- Stock Market
- Equities
- AXNX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















